{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T06:04:31Z","timestamp":1791266671422,"version":"4.1.0"},"reference-count":37,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T00:00:00Z","timestamp":1428364800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0122860","type":"journal-article","created":{"date-parts":[[2015,4,7]],"date-time":"2015-04-07T14:26:00Z","timestamp":1428416760000},"page":"e0122860","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":3,"title":["Clinical Outcomes in Low Risk Coronary Artery Disease Patients Treated with Different Limus-Based Drug-Eluting Stents - A Nationwide Retrospective Cohort Study Using Insurance Claims Database"],"prefix":"10.1371","volume":"10","author":[{"given":"Chao-Lun","family":"Lai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Fen","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond Nien-Chen","family":"Kuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yen-Yun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Fong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K. Arnold","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-Shu","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,7]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1056\/NEJM199408253310801","article-title":"A comparison of balloon-expandable-stent implantation with balloon angioplasty in patients with coronary artery disease. Benestent Study Group","volume":"331","author":"PW Serruys","year":"1994","journal-title":"N Engl J Med"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1056\/NEJM199408253310802","article-title":"A randomized comparison of coronary-stent placement and balloon angioplasty in the treatment of coronary artery disease. Stent Restenosis Study Investigators","volume":"331","author":"DL Fischman","year":"1994","journal-title":"N Engl J Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(07)61444-5","article-title":"Outcomes associated with drug-eluting and bare-metal stents: a collaborative network meta-analysis","volume":"370","author":"C Stettler","year":"2007","journal-title":"Lancet"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ccd.22533","article-title":"Four-year clinical outcome of sirolimus- and paclitaxel-eluting stents compared to bare-metal stents for the percutaneous treatment of stable coronary artery disease","volume":"76","author":"C Simsek","year":"2010","journal-title":"Catheter Cardiovasc Interv"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/j.jacc.2009.04.077","article-title":"5-year clinical outcomes after sirolimus-eluting stent implantation: Insights from a patient-level pooled analysis of 4 randomized trials comparing sirolimus-eluting stents with bare-metal stents","volume":"54","author":"A Caixeta","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa067193","article-title":"Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents","volume":"356","author":"GW Stone","year":"2007","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1056\/NEJMoa067731","article-title":"Stent thrombosis in randomized clinical trials of drug-eluting stents","volume":"356","author":"L Mauri","year":"2007","journal-title":"N Engl J Med"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jacc.2008.09.058","article-title":"2-year clinical outcomes after implantation of sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry)","volume":"53","author":"A Kaltoft","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S0140-6736(07)60314-6","article-title":"Early and late coronary stent thrombosis of sirolimus-eluting and paclitaxel-eluting stents in routine clinical practice: data from a large two-institutional cohort study","volume":"369","author":"J Daemen","year":"2007","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jacc.2007.06.047","article-title":"A meta-analysis of 16 randomized trials of sirolimus-eluting stents versus paclitaxel-eluting stents in patients with coronary artery disease","volume":"50","author":"A Schomig","year":"2007","journal-title":"J Am Coll Cardiol"},{"key":"ref11","first-page":"393","article-title":"Everolimus-eluting stents in interventional cardiology","volume":"8","author":"JC Townsend","year":"2012","journal-title":"Vasc Health Risk Manag"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.jacc.2008.04.030","article-title":"Endothelial cell recovery between comparator polymer-based drug-eluting stents","volume":"52","author":"M Joner","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jacc.2012.01.073","article-title":"Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (Xience V Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial","volume":"60","author":"SH Hofma","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.ijcard.2011.01.015","article-title":"Twelve-month clinical outcomes of everolimus-eluting stent as compared to paclitaxel- and sirolimus-eluting stent in patients undergoing percutaneous coronary interventions. A meta-analysis of randomized clinical trials","volume":"150","author":"S Cassese","year":"2011","journal-title":"Int J Cardiol"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1016\/j.jacc.2006.08.035","article-title":"Comparison of zotarolimus-eluting and sirolimus-eluting stents in patients with native coronary artery disease: a randomized controlled trial","volume":"48","author":"DE Kandzari","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"ref16","first-page":"543","article-title":"Late-term clinical outcomes with zotarolimus- and sirolimus-eluting stents. 5-year follow-up of the ENDEAVOR III (A Randomized Controlled Trial of the Medtronic Endeavor Drug [ABT-578] Eluting Coronary Stent System Versus the Cypher Sirolimus-Eluting Coronary Stent System in De Novo Native Coronary Artery Lesions)","volume":"4","author":"DE Kandzari","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1016\/S0140-6736(10)60208-5","article-title":"Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial","volume":"375","author":"K Rasmussen","year":"2010","journal-title":"Lancet"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.jcin.2012.04.008","article-title":"3-Year clinical outcomes in the randomized SORT OUT III superiority trial comparing zotarolimus- and sirolimus-eluting coronary stents","volume":"5","author":"M Maeng","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.healthpol.2004.02.006","article-title":"Application of a single sampling plan for auditing medical-claim payments made by Taiwan National Health Insurance","volume":"70","author":"HH Fu","year":"2004","journal-title":"Health Policy"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S0929-6646(10)60120-9","article-title":"Guidelines of the Taiwan Society of Cardiology for the Management of Hypertension","volume":"109","author":"CE Chiang","year":"2010","journal-title":"J Formos Med Assoc"},{"key":"ref21","first-page":"63","article-title":"Guidelines of the Taiwan Society of Cardiology (TSOC) for the Management of ST-Segment Elevation Myocardial Infarction","volume":"28","author":"YH Li","year":"2012","journal-title":"Acta Cardiol Sin"},{"key":"ref22","first-page":"161","article-title":"Guidelines of the Taiwan Society of Cardiology (TSOC) for the Diagnosis and Treatment of Heart Failure","volume":"28","author":"CC Wang","year":"2012","journal-title":"Acta Cardiol Sin"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"500","DOI":"10.2188\/jea.JE20140076","article-title":"Validation of Acute Myocardial Infarction Cases in the National Health Insurance Research Database in Taiwan","volume":"24","author":"CL Cheng","year":"2014","journal-title":"J Epidemiol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1093\/ije\/29.2.336","article-title":"Accuracy of cause-of-death coding in Taiwan: types of miscoding and effects on mortality statistics","volume":"29","author":"TH Lu","year":"2000","journal-title":"Int J Epidemiol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1097\/01.mlr.0000182534.19832.83","article-title":"Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data","volume":"43","author":"H Quan","year":"2005","journal-title":"Med Care"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.jacc.2010.06.007","article-title":"Coronary stents: current status","volume":"56","author":"S Garg","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.jcin.2010.07.008","article-title":"Improved late clinical safety with zotarolimus-eluting stents compared with paclitaxel-eluting stents in patients with de novo coronary lesions: 3-year follow-up from the ENDEAVOR IV (Randomized Comparison of Zotarolimus- and Paclitaxel-Eluting Stents in Patients With Coronary Artery Disease) trial","volume":"3","author":"MB Leon","year":"2010","journal-title":"JACC Cardiovasc Interv"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1161\/CIRCULATIONAHA.108.803528","article-title":"Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial","volume":"119","author":"GW Stone","year":"2009","journal-title":"Circulation"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/S0140-6736(12)61336-1","article-title":"Stent thrombosis and major clinical events at 3 years after zotarolimus-eluting or sirolimus-eluting coronary stent implantation: a randomised, multicentre, open-label, controlled trial","volume":"380","author":"E Camenzind","year":"2012","journal-title":"Lancet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.jacc.2010.03.086","article-title":"Comparison of zotarolimus-eluting stents with sirolimus- and paclitaxel-eluting stents for coronary revascularization: the ZEST (comparison of the efficacy and safety of zotarolimus-eluting stent with sirolimus-eluting and paclitaxel-eluting stent for coronary lesions) randomized trial","volume":"56","author":"DW Park","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"f6530","DOI":"10.1136\/bmj.f6530","article-title":"Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis","volume":"347","author":"EP Navarese","year":"2013","journal-title":"BMJ"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.jacc.2012.01.073","article-title":"Second-generation everolimus-eluting stents versus first-generation sirolimus-eluting stents in acute myocardial infarction. 1-year results of the randomized XAMI (XienceV Stent vs. Cypher Stent in Primary PCI for Acute Myocardial Infarction) trial","volume":"60","author":"SH Hofma","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1161\/CIRCULATIONAHA.111.063644","article-title":"Randomized comparison of everolimus-eluting and sirolimus-eluting stents in patients treated with percutaneous coronary intervention: the Scandinavian Organization for Randomized Trials with Clinical Outcome IV (SORT OUT IV)","volume":"125","author":"LO Jensen","year":"2012","journal-title":"Circulation"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1016\/j.jacc.2012.07.004","article-title":"2-year patient-related versus stent-related outcomes: the SORT OUT IV (Scandinavian Organization for Randomized Trials With Clinical Outcome IV) Trial","volume":"60","author":"LO Jensen","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/CIRCULATIONAHA.112.104059","article-title":"Comparison of everolimus-eluting and sirolimus-eluting coronary stents: 1-year outcomes from the Randomized Evaluation of Sirolimus-eluting Versus Everolimus-eluting stent Trial (RESET)","volume":"126","author":"T Kimura","year":"2012","journal-title":"Circulation"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1016\/j.jacc.2011.07.031","article-title":"Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience\/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial","volume":"58","author":"KW Park","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.ahj.2012.08.007","article-title":"Safety and efficacy of everolimus- versus sirolimus-eluting stents: a systematic review and meta-analysis of 11 randomized trials","volume":"165","author":"KW Park","year":"2013","journal-title":"Am Heart J"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0122860","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T22:36:17Z","timestamp":1566513377000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0122860"}},"subtitle":[],"editor":[{"given":"Ho-Chang","family":"Kuo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,7]]},"references-count":37,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,7]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0122860","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,7]]}}}